Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations
- 25 October 2005
- journal article
- review article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 391 (3) , 449-464
- https://doi.org/10.1042/bj20050872
Abstract
Steroid hormones are important endocrine signalling molecules controlling reproduction, development, metabolism, salt balance and specialized cellular responses, such as inflammation and immunity. They are lipophilic in character and act by binding to intracellular receptor proteins. These receptors function as ligand-activated transcription factors, switching on or off networks of genes in response to a specific hormone signal. The receptor proteins have a conserved domain organization, comprising a C-terminal LBD (ligand-binding domain), a hinge region, a central DBD (DNA-binding domain) and a highly variable NTD (N-terminal domain). The NTD is structurally flexible and contains surfaces for both activation and repression of gene transcription, and the strength of the transactivation response has been correlated with protein length. Recent evidence supports a structural and functional model for the NTD that involves induced folding, possibly involving α-helix structure, in response to protein–protein interactions and structure-stabilizing solutes.Keywords
This publication has 137 references indexed in Scilit:
- Intrinsically unstructured proteins and their functionsNature Reviews Molecular Cell Biology, 2005
- Estrogen Receptor-α Directs Ordered, Cyclical, and Combinatorial Recruitment of Cofactors on a Natural Target PromoterCell, 2003
- How Transcriptional Activators Bind Target ProteinsPublished by Elsevier ,2001
- Interaction of estrogen receptors α and β with estrogen response elementsMolecular and Cellular Endocrinology, 2001
- Androgen Receptor Interacts with the Positive Elongation Factor P-TEFb and Enhances the Efficiency of Transcriptional ElongationJournal of Biological Chemistry, 2001
- Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated TranscriptionCell, 2000
- Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonistThe EMBO Journal, 1999
- Delineation of Two Distinct Type 1 Activation Functions in the Androgen Receptor Amino-terminal DomainJournal of Biological Chemistry, 1996
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences, 1996
- Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-ANature, 1986